PubMed Health⌕ Search

Biomedical subjects

C N Eustance

Publications and source records attributed to C N Eustance.

3 recordsLinked to original sources

Evaluating the Swirler nebulizer: a user's perspective.

The change from multi-use to single-use nebulizer systems could potentially result in greatly increased expense for aerosol ventilation imaging and a larger waste disposal problem. We have therefore investigated a new compact single-use nebulizer system, the Swirler (Amici), for ventilation lung imaging using 99Tcm-DTPA aerosol. Seventy-five patients requiring lung ventilation/perfusion imaging were studied. The ventilation imaging was assessed using three different fills: Group 1, 1000 MBq in 2 ml; Group 2, 1000 MBq in 4 ml; and Group 3, 2000 MBq in 4 ml. The nebulization times to give 1200 counts s-1 on the posterior ventilation image were similar for Groups 1 and 3 (mean 4 min) but slower for Group 2 (mean 6 min). Room contamination was very low when performed in a room with an extractor device. The mean room air contamination was 117.0 Bq l-1 min-1 for Group 1 amd 27.6 Bq l-1 min-1 for Group 2, comparable to previous nebulizers we have used. Dose rates measured at the surface of the lead shielded nebulizer were 6.8 microSv h-1 for 1000 MBq in 2 ml and 10.9 microSv h-1 for 2000 MBq in 4 ml. The mass median diameter (span) without the extension tubing was 1.39 microns (1.85) and with a small extension tube reduced to 1.11 microns (1.70). Qualitative and quantitative assessment of image quality showed good peripheral airways penetration of particles with no uninterpretable scans, comparable with other systems we have used. In practical terms, the device is much more compact than other systems and therefore generates a much smaller volume of waste. It is an easy device to use. However, when ventilating patients supine or erect, we found that it was necessary to use the small extension tube.

Aerosols↗

Ventilation and perfusion lung imaging--which nebulizer?

Three commercially available 99Tcm-diethylenetriamine pentaacetate (99Tcm-DTPA) aerosol delivery nebulizers for lung ventilation imaging were investigated. Two were air-jet systems, 'Optimist' (Medicaid) and 'Microcirrus' (Amersham), and one was an ultrasonic device (Europlus). Altogether, 112 consecutive patients were scanned, 37 using the Optimist, 40 using the Microcirrus and 35 the Europlus. The age mix, FEV1, FVC and PEFR measurements of the patients in each group were similar. Each contained a proportion of patients with poor respiratory function, with PEFR rates ranging from 30 to 582 l min-1 for patients studied with all systems. Ease of use, image quality and cost were evaluated as well as radioactive and microbiological contamination. The Optimist system gave the best combination of image quality and cost, and was associated with the lowest level of radioactive contamination. It also proved the most popular. Airborne contamination for all nebulizers was lower than previously reported and was largely dependent on patient compliance. With poorly compliant patients, the contamination levels are sufficient to warrant an extraction device. There was no evidence of bacterial contamination of the nebulizers or tubing on repeated use over 5 days.

Forced Expiratory Volume↗

Radiation dose rates from adult patients receiving 131I therapy for thyrotoxicosis.

Recommendations for restricting the exposure to radiation of members of the public coming into contact with thyrotoxic patients treated with 131I are currently based on the activity retained by the patient, and not on the doses likely to be received by such individuals. In order to examine whether these current implications of a reduction in this limit to 1 mSv, measurements were made of the dose rates at distances of 0.1, 0.5 and 1.0 m from 60 patients just before they left the nuclear medicine department. These measurements were repeated 1, 3, 6, 8 and 10 days after administration for 30 patients, and the radioactivity in samples of saliva taken on each of these days and secreted in sweat over the first 24 h were also measured. Doses were estimated for administered activities of approximately 200-600 MBq, assuming appropriate values for the times and distances spent near other individuals while travelling, at work, at home and near to young children considered in three age groups (< 2, 2-5 and 5-11 years). Periods of restriction were derived which would reduce these doses to 5 or 1 mSv. For a dose limit of 5 mSv, there is no need to restrict private travel, public transport journeys can last up to 7 h, a patient can return to work immediately, but sleeping with a partner will have to be restricted even for the minimum activity of 200 MBq.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗